Monopar Therapeutics Inc.

Direct answer

Monopar Therapeutics Inc. is publicly traded on NASDAQ under the ticker MNPR.

Monopar Therapeutics Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to pioneering novel cancer treatments within the United States. Its leading investigational drug, Validive, a specialized clonidine hydrochloride mucobuccal tablet, is currently undergoing Phase 2b/3 clinical trials. This therapy aims to prevent severe oral mucositis, a debilitating side effect of chemoradiotherapy, in...

Can you invest in Monopar Therapeutics Inc.?

Yes. Monopar Therapeutics Inc. is publicly traded on NASDAQ under the ticker MNPR.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Monopar Therapeutics Inc.

Detailed equity research is provided by MarketSnap.